![Pierre Merville's research works | French National Centre for Scientific Research, Paris (CNRS) and other places Pierre Merville's research works | French National Centre for Scientific Research, Paris (CNRS) and other places](https://www.researchgate.net/publication/370440138/figure/fig1/AS:11431281154754683@1682992737183/Flowchart-of-the-trial-design-H2L-HEMO2lifeR-SOC-Standard-of-Care_Q320.jpg)
Pierre Merville's research works | French National Centre for Scientific Research, Paris (CNRS) and other places
![WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5 WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5](https://online.pubhtml5.com/hegn/vbgb/files/large/201.jpg)
WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5
πππ ππππππππ πΈππ - π΅πππππππππ π²πΌπΎ
![81MMoXZ7pqL._CLa|2933,2131|710gm47sRkL.jpg,71jY6ESkzbL.jpg|0,0,1333,2131+1600,0,1333,2131+666,0,1600,2131_._SY200_.jpg 81MMoXZ7pqL._CLa|2933,2131|710gm47sRkL.jpg,71jY6ESkzbL.jpg|0,0,1333,2131+1600,0,1333,2131+666,0,1600,2131_._SY200_.jpg](https://m.media-amazon.com/images/I/81MMoXZ7pqL._CLa%7C2933,2131%7C710gm47sRkL.jpg,71jY6ESkzbL.jpg%7C0,0,1333,2131+1600,0,1333,2131+666,0,1600,2131_._SY200_.jpg)
81MMoXZ7pqL._CLa|2933,2131|710gm47sRkL.jpg,71jY6ESkzbL.jpg|0,0,1333,2131+1600,0,1333,2131+666,0,1600,2131_._SY200_.jpg
![WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5 WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5](https://online.pubhtml5.com/hegn/vbgb/files/large/202.jpg)
WCLC2016_Onsite Program_vF_low res - Cell lung cancer-Small cell lung-Lung cancer patients | PubHTML5
![5109ov69KiL._CLa|575,500|510pTd3RgoL.jpg,51Keq7VIFcL.jpg|0,0,261,500+314,0,261,500+130,0,314,500__._SX400_SY326_.jpg 5109ov69KiL._CLa|575,500|510pTd3RgoL.jpg,51Keq7VIFcL.jpg|0,0,261,500+314,0,261,500+130,0,314,500__._SX400_SY326_.jpg](https://m.media-amazon.com/images/I/5109ov69KiL._CLa%7C575%2C500%7C510pTd3RgoL.jpg%2C51Keq7VIFcL.jpg%7C0%2C0%2C261%2C500%2B314%2C0%2C261%2C500%2B130%2C0%2C314%2C500__._SX400_SY326_.jpg)
5109ov69KiL._CLa|575,500|510pTd3RgoL.jpg,51Keq7VIFcL.jpg|0,0,261,500+314,0,261,500+130,0,314,500__._SX400_SY326_.jpg
![Impact of Process Conditions on the Sintering Behavior of an Alumina-Supported Cobalt FischerβTropsch Catalyst Studied with an in Situ Magnetometer | ACS Catalysis Impact of Process Conditions on the Sintering Behavior of an Alumina-Supported Cobalt FischerβTropsch Catalyst Studied with an in Situ Magnetometer | ACS Catalysis](https://pubs.acs.org/cms/10.1021/cs501810y/asset/images/medium/cs-2014-01810y_0011.gif)
Impact of Process Conditions on the Sintering Behavior of an Alumina-Supported Cobalt FischerβTropsch Catalyst Studied with an in Situ Magnetometer | ACS Catalysis
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway | ACS Nano
![61o2Ewxlr4L._CLa|1516,1263|61m2mgO66dL.jpg,61g+H-fOCKL.jpg|0,0,689,1263+827,0,689,1263+344,0,827,1263_._SY200_.jpg 61o2Ewxlr4L._CLa|1516,1263|61m2mgO66dL.jpg,61g+H-fOCKL.jpg|0,0,689,1263+827,0,689,1263+344,0,827,1263_._SY200_.jpg](https://m.media-amazon.com/images/I/61o2Ewxlr4L._CLa%7C1516,1263%7C61m2mgO66dL.jpg,61g+H-fOCKL.jpg%7C0,0,689,1263+827,0,689,1263+344,0,827,1263_._SY200_.jpg)
61o2Ewxlr4L._CLa|1516,1263|61m2mgO66dL.jpg,61g+H-fOCKL.jpg|0,0,689,1263+827,0,689,1263+344,0,827,1263_._SY200_.jpg
![Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway | ACS Nano Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.8b05189/asset/images/large/nn-2018-05189g_0001.jpeg)